Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Rescue Therapeutics Inc.
DescriptionAnsamycin-class compound designed to enhance the efficacy of secondline therapy DOXIL (doxorubicin) in drug-resistant cancer cells
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationOvarian cancer
Indication DetailsTreat ovarian cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today